Search results
Results from the WOW.Com Content Network
Jan. 24—SEATTLE — Johnson and Johnson will pay nearly $150 million to Washington for its role in the opioid epidemic, the Washington State Office of Attorney General announced Tuesday. The ...
Nov. 10—The Oklahoma Supreme Court on Tuesday decided in favor of opioid painkiller manufacturer Johnson & Johnson, overturning a 2019 decision that mandated the company pay $465 million for its ...
Johnson & Johnson (J&J) is an American multinational pharmaceutical, ... and in October J&J paid $20.4 million to two Ohio counties fighting the opioid epidemic. ...
For premium support please call: 800-290-4726 more ways to reach us
The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical ...
In 2021, Ravnsborg supported South Dakota opting into a $26 billion, multi-state settlement with the three major opioid distributors (Cardinal Health, McKesson Corp., and AmerisourceBergen) and Johnson & Johnson to resolve claims that the companies helped fuel the opioid epidemic.
Two pharmaceutical giants were ordered to pay $266 million to the city of Baltimore after a jury found them liable of fueling the opioid crisis, a nationwide epidemic of addiction that kills tens ...
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.